![Bryant Fong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryant Fong
Directeur/Membre du Conseil chez
JHL BIOTECH, INC.
Profil
Mr. Bryant E.
Fong is a Partner & Co-Portfolio Manager at Stonepine Capital Management LLC, a Venture Partner at FinHealth Gestão de Recursos SA, a Founder & Managing Director at Biomark Capital Management Co. LLC and a Chief Executive Officer & Chief Financial Officer at I2Dx, Inc. He is on the Board of Directors at Eden Biologics, Inc., Alinea Pharmaceuticals, Inc., Biozeus Biopharmaceutical SA, Odyssey Thera, Inc. and WaveTec Vision Systems, Inc. He has approximately over 28 years of life science industry research, advisory, operational and venture capital experience.
Mr. Fong was previously employed as an Independent Director by Deep Medicine Acquisition Corp., an Independent Director by ADMA Biologics, Inc., a Managing Director by Burrill & Co. LLC, and a President by Nora Therapeutics, Inc. He also served on the board at Acusphere, Inc., Neos Therapeutics, Inc., AliveCor, Inc., Catalyst Bioscience, Inc. /Old/, Cengent Therapeutics, Inc., FerroKin BioSciences, Inc., Logical Therapeutics, Inc., Neurotech Pharmaceuticals, Inc. (United States), Pharmasset, Inc. and TRF Pharma, Inc.
He is a graduate in biochemistry of University of California at Berkeley.
Postes actifs de Bryant Fong
| Sociétés | Poste | Début |
|---|---|---|
| JHL BIOTECH, INC. | Directeur/Membre du Conseil | 17/12/2012 |
FinHealth Gestão de Recursos SA
 FinHealth Gestão de Recursos SA Investment ManagersFinance FinHealth is an active manager which provides equity financing for middle-market and early-stage capital requirements. The firm targets companies operating in the healthcare sector, and industries such as health services, biopharmaceuticals, digital health and CROs and medical/ diagnostic equipment and services. It invests in corporations located in Brazil. | Private Equity Investor | 01/01/2014 |
Biozeus Biopharmaceutical SA
 Biozeus Biopharmaceutical SA Miscellaneous Commercial ServicesCommercial Services Develops therapies for the treatment of diabetes and obesity | Directeur/Membre du Conseil | - |
WaveTec Vision Systems, Inc.
 WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology Develops and provides wavefront measurement technologies | Directeur/Membre du Conseil | - |
I2Dx, Inc.
 I2Dx, Inc. Packaged SoftwareTechnology Services Develops diagnostic platform for the assessment of prodromal Alzheimer’s disease | Directeur Général | - |
Biomark Capital Management Co. LLC
 Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital invests in companies located in the United States primarily in North America, along with a specific focus in Russia, Taiwan, India and China. The firm targets companies operating in the fields of the therapeutics, medical devices, molecular diagnostics, healthcare delivery and information technology service sectors. It provides financing for early, mid and later stage capital transactions with an investment size of USD 5 - 10 million. | Private Equity Investor | 01/11/2013 |
Alinea Pharmaceuticals, Inc.
 Alinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for diabetes and related metabolic disorders | Directeur/Membre du Conseil | - |
Odyssey Thera, Inc.
 Odyssey Thera, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | - |
Stonepine Capital Management LLC
 Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Gestionnaire de Portefeuille-Actions | 01/06/2024 |
Anciens postes connus de Bryant Fong
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Bryant Fong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Acusphere, Inc.
 Acusphere, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Catalyst Bioscience, Inc. /Old/
 Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets catalytic biopharmaceutical products | Health Technology |
Cengent Therapeutics, Inc.
 Cengent Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches & develops pharmaceutical drugs | Commercial Services |
Alinea Pharmaceuticals, Inc.
Alinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for diabetes and related metabolic disorders | Health Technology |
ADMA Biologics, Inc.
 ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
WaveTec Vision Systems, Inc.
WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology Develops and provides wavefront measurement technologies | Electronic Technology |
TRF Pharma, Inc.
 TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Stonepine Capital Management LLC
Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Finance |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Odyssey Thera, Inc.
Odyssey Thera, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Logical Therapeutics, Inc.
 Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products that treat diseases associated with inflammation | Health Technology |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides therapeutic treatments for infertility and miscarriages | Health Technology |
AliveCor, Inc.
 AliveCor, Inc. Medical SpecialtiesHealth Technology Develops mobile heart monitoring systems | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Biomark Capital Management Co. LLC
Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital invests in companies located in the United States primarily in North America, along with a specific focus in Russia, Taiwan, India and China. The firm targets companies operating in the fields of the therapeutics, medical devices, molecular diagnostics, healthcare delivery and information technology service sectors. It provides financing for early, mid and later stage capital transactions with an investment size of USD 5 - 10 million. | Finance |
I2Dx, Inc.
I2Dx, Inc. Packaged SoftwareTechnology Services Develops diagnostic platform for the assessment of prodromal Alzheimer’s disease | Technology Services |
Biozeus Biopharmaceutical SA
Biozeus Biopharmaceutical SA Miscellaneous Commercial ServicesCommercial Services Develops therapies for the treatment of diabetes and obesity | Commercial Services |
FinHealth Gestão de Recursos SA
FinHealth Gestão de Recursos SA Investment ManagersFinance FinHealth is an active manager which provides equity financing for middle-market and early-stage capital requirements. The firm targets companies operating in the healthcare sector, and industries such as health services, biopharmaceuticals, digital health and CROs and medical/ diagnostic equipment and services. It invests in corporations located in Brazil. | Finance |
Deep Medicine Acquisition Corp.
 Deep Medicine Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
